Dyno Therapeutics
PrivateLast Round
Series A
May 6, 2021
Est. Valuation
$539.27M
Total Funding Raised
$109M
Company Overview
Dyno Therapeutics is a biotechnology company that provides advanced technologies for innovative gene therapies through its AI-driven platform, which integrates next-generation DNA synthesis of AAV capsids with high-throughput sequencing and machine learning to facilitate safe and efficient in vivo delivery of novel AAV vectors for medical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dyno Therapeutics Comparables
Compare Dyno Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 83% | |
| Shape Therapeutics | 81% | |
| Voyager Therapeutics | 78% |
Dyno Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 6, 2021 | ||||
| Seed | Nov 1, 2018 |
Key People
Founding team and executive leadership
Dyno Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| GV | Series A |
| Lux Capital | Series A |
| Obvious Ventures | Series A |
| CRV | Series A, Seed |
| Casdin Capital | Series A |
| Polaris Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
Open release of curated synthetic domain interfaces dataset.
- Mar 18, 2026
Attended and launched a product at the GTC 2026 conference.
Dyno Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dyno Therapeutics's valuation, stock price, and market status.
Is Dyno Therapeutics a public or private company?
Dyno Therapeutics is a private company.
What is the current stock price of Dyno Therapeutics?
Dyno Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Dyno Therapeutics worth (valuation)?
Valuation information for Dyno Therapeutics is not publicly available.
Can I buy Dyno Therapeutics stock?
Dyno Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Dyno Therapeutics's last funding round?
Dyno Therapeutics's most recent funding round was Series A on May 6, 2021.
Who are the main investors in Dyno Therapeutics?
Key investors in Dyno Therapeutics include Andreessen Horowitz, CRV, Polaris Partners.
Will Dyno Therapeutics IPO soon?
No public IPO plans have been announced for Dyno Therapeutics.
How can I track Dyno Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dyno Therapeutics's secondary market activity and sign up for updates.